期刊文献+

2型糖尿病肾病危险因素探讨 被引量:4

Clinic feature and risk factors of type 2 diabetic nephropathy
原文传递
导出
摘要 目的探讨2型糖尿病肾病的临床特点及易患因素,指导临床防治。方法分析256例2型糖尿病患者,根据尿白蛋白排泄率和肾功能将糖尿病患者分为糖尿病无肾病组、早期肾病组、临床肾病组、终末期肾病组对照比较。结果糖尿病4组间在年龄、病程,合并高血压、高血脂、高血尿酸、冠心病、胆结石病史、糖尿病眼病、糖尿病周围神经病变、糖尿病足,收缩压、舒张压、脉压及血糖水平差异有统计学意义(P〈0.05);糖尿病病程、收缩压、脂代谢紊乱对糖尿病肾病的发病率有显著影响(P〈0.05)。结论血压、血糖、血脂控制不良导致糖尿病肾病的进展,糖尿病之间慢性血管并发症密切相关。定期检测白蛋白排泄率与血脂,严格控制血糖和血压,纠正脂代谢紊乱,有助于防治糖尿病肾病。 Objective To investigate the clinical features of type 2 diabetic nephropathy and analyze the risk factors of affecting incidence in order to achieve better prevention and treatment. Method A retrospective analysis of clinical features of diabetic nephropathy was conducted based on 256 cases in our department from 2001 to 2006. They were 87 diabetes mellitus without nephropathy, 65 early stage diabetic nephmpathy, 66 diabetic nephmpathy with overt protein urine, 38 end - stage diabetes nephmpathy. Serum levels of lipid, glucose, urea nitrogen, creadnine, uric acid, blood pressure, and albumin urine were monitored in the four groups, and their levels were compared. Results Age, course of disease, hypertension, hyperlipidemia, hyperuricemia, coronary heart disease, biliary calculus, diabetic refinopathy, diabetic peripheral neumpathydiabetic foot, systolic and diastolic blood pressure were significantly different among four diabetic subgroups ( P 〈 0. 05). Course of diabetes, systolic blood pressure and hyperlipidemia had significant positive effect on the incidence of diabetic nephmpathy ( P 〈 0.05). Conclusion Dissatisfaction control of blood pressure, blood sugar and lipid result in the progression of diabetic nephmpathy. Diabetic nephmpathy is closely associated with other vascular complications. It is an effective way to prevent and treat diabetic nephmpathy through periodically inspecting urine albumin excretion rate, strictly controlling blood pressure and blood sugar, and correcting dyslipidemia.
出处 《中国医师杂志》 CAS 2007年第10期1347-1349,共3页 Journal of Chinese Physician
关键词 糖尿病肾病/病理学/病因学 危险因素 Diabetic nephropathies/PA/ET Risk factors
  • 相关文献

参考文献9

  • 1Romero R. Diabetic nephropathy: strategies for prevention. Nefrologia, 2002,22( 1 ) :46.
  • 2Joss N, Paterson KR, Deighan C J, et al. Diabetic nephropathy: how effective is treatment in clinical practice. Q J Med,2002,95( 1 ) :41.
  • 3Zhao HL, Thomas GN, Leung W. An update on the management of nephropathy in type 2 diabetes. J Chin Med Assoc, 2003,66 ( 11 ) : 627- 636.
  • 4Athyros VG, Papageorgiou AA, Elisaf M, et al. Statins and renal function in parients with diabetes mellitus. Curr Med Res Opin, 2003, 19 (7) : 615-617.
  • 5王爱民,雷闽湘,刘泽灏,张军,陈卓雄,孙曙光.2型糖尿病肾病危险因素分析[J].中国现代医学杂志,2005,15(1):116-119. 被引量:28
  • 6Karavanake K, Baum JD. Coexistence of impaired indices of autonomic neuropathy and diabetic nephropathy in a cohort of children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab,2003,16( 1 ) :79.
  • 7Andersen S, Jacobsen P, Tarnow L, et al. Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy, Nephrol. Dial Transplant,2003,18(2) :293.
  • 8Bakris GL, Weir MR, Shanefar AR S, et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med, 2003,163 ( 13 ) : 1555.
  • 9Esmatjes E, De-Alvaro F, ESTUDI DIAMANTEIN VESTIGATORS. Incidence of diabetic nephropathy in Tyoe 1 diabetic patients in Spain : Estudio Kiamante. Diabetes Res Clin Pract,2002,57 (1) :35.

二级参考文献16

  • 1ATHYROS VG, PAPAGEORGIOU AA, ELISAF M, et al. Statins and renal function in patients with diabetes mellitus[J]. Curr Med Res Opin, 2003, 19(7): 615-617.
  • 2BERFIELD AK, ANDRESS DL, ABRASS CK. IGF-l-induced lipid accumulation impairs mesangial cell migration and contractile function[J]. Kidney Int, 2002,62(4): 1229.
  • 3KARAVANAKI K, BAUM JD. Coexistence of impaired indices of autonomic neuropathy and diabetic nephropathy in a cohort of children with type 1 diabetes mellitus [J]. J Pediatr Endocrinol Metab, 2003, 16(1): 79.
  • 4CHRISTENSEN PK, ROSSING P, NIELSEN FS, et aL Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy[.I]. Diabet Med. 1999, 16(5): 388.
  • 5ANDERSEN S, JACOBSEN P, TARNOW L, et al. Time course of the antiprotelnuric and antihypertensive effect of losartan in diabetic nephropathy, Nephrol[J]. Dial Transplant, 2003, 18(2):293.
  • 6NARITA T, KAKEI M, ITO S. Aggressive antihypertensive treatment and serum lipid lowering therapy are necessary to prevent deterioration of the renal function even in elderly type 2 diabetic patients with persistent albuminuria [J]. Gerontology,2002, 48(5): 302.
  • 7BAKRIS GL, WEIR MR, SHANIFAR S, et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study[J]. Arch Intern Med, 2003, 163(13):1555.
  • 8GAMBARO G, BAX G, FUSARO M, et al. Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus[J]. Diabetes Nutr Metab, 2001,14(6): 337.
  • 9ESMATJES E, DE-ALVARO F, 'ESTUDIO DIAMANTE' INVESTIGATORS. Incidence of diabetic nephropathy in Type 1 diabetic patients in Spain: 'Estudio Diamante'[J]. Diabetes Res Clin Prac4 2002, 57(1): 35.
  • 10MARTINEZ-CASTELAO A, RAMOS R, GONZALEZ MT, et al.Dyslipidemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy [J]. Nefrologia,2002, 22 (1): 51.

共引文献27

同被引文献72

引证文献4

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部